Ratnakar Securities Pvt. Ltd.

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private

BSE342.50-8.6 (-2.45 %)

PREV CLOSE ( ) 351.10

OPEN PRICE ( ) 358.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 34334

TODAY'S LOW / HIGH ( )340.00 358.00

52 WK LOW / HIGH ( ) 219449

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1951

Management Info

- Chairman Prashant Nagre - Managing Director

Registered Office

Address A 1501, Thane One,Dil Complex, Ghodbhunder Road,Majiwada,
Thane,
Maharashtra-400610

Phone 022-66230800

Email info@fermentabiotech.com

Website www.fermentabiotech.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

30Jul Fermenta Biotech secures CEP from EDQM
Fermenta Biotech has received the Certificate of Suitability (CEP) from..

21Jul Fermenta Biotech informs about certifi
Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and..

11Jul Fermenta Biotech enters into strategic
Fermenta Biotech has entered into a strategic memorandum of understandin..

29Apr Fermenta Biotech informs about non-app
In connection with SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated Novem..

17Apr Fermenta Biotech informs about disclos
Pursuant to Regulation 30 of the Securities and Exchange Board of India..

Financials

in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	162.35	676.16
Gross Profit	227.2	744.21
Operating Profit	313.72	1117.93
Net Sales	1190.19	4305.32

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Mankind Pharma (BSE) 2638.15 (2.70%)	M.Cap ( in Cr)108891.88
Glenmark Pharma (BSE) 2110.00 (3.33%)	M.Cap ( in Cr)59544.37
Divi's Lab (BSE) 6102.25 (0.85%)	M.Cap ( in Cr)161995.56
Aurobindo Pharma (BSE) 1128.50 (2.94%)	M.Cap ( in Cr)65543.46
Laurus Labs (BSE) 923.00 (3.30%)	M.Cap ( in Cr)49825.84

Shareholding Pattern

	PROMOTERS	64.09%
	NON-INSTITUTION	35.89%
	FI/BANKS/INSURANCE	0%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal BSE H...	0.02

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

FERMENTA BIOTECH LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES